MedMen Enterprises
(CNSX) MMEN
MedMen Enterprises Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$120.13M
Net Income (TTM)
$152.83M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
MMEN News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout MedMen Enterprises
Industry
Pharmaceuticals
Sector
Health CareEmployees
875
CEO
Edward J. Record, MBA
Website
www.medmen.comHeadquarters
Los Angeles, CA 90045, US
MMEN Financials
Key Financial Metrics (TTM)
Gross Margin
50%
Operating Margin
-44%
Net Income Margin
-1%
Return on Equity
-96%
Return on Capital
19%
Return on Assets
-51%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$69.73M
Operating Income
$61.30M
EBITDA
$63.66M
Operating Cash Flow
$62.53M
Capital Expenditure
$9.66M
Free Cash Flow
$72.19M
Cash & ST Invst.
$13.53M
Total Debt
$395.84M
MedMen Enterprises Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$27.22M
-22.8%
Gross Profit
$13.15M
-23.6%
Gross Margin
48.29%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
428
N/A
Net Income
$31.21M
-60.3%
EBITDA
$21.60M
-262.7%
Quarterly Fundamentals
Net Cash
$371.56M
+1.2%
Accounts Receivable
$3.86M
-58.9%
Inventory
$14.67M
+22.9%
Long Term Debt
$67.41M
-76.4%
Short Term Debt
$311.77M
+196.3%
Return on Assets
-51.22%
N/A
Return on Invested Capital
19.20%
N/A
Free Cash Flow
$13.00M
-16.4%
Operating Cash Flow
$14.84M
+6.6%